Research at the conference also included updates to the associations between hormone therapy and Alzheimer’s risk. Previous studies had suggested that women who start taking hormones in their late 60s and 70s have a higher rate of cognitive decline, a paper out of the University of Wisconsin school of medicine and public health found that risk to be elevated specifically for women with diabetes.
University Communications